Source: Mobidiag Blog

Mobidiag Blog Hologic closes acquisition of Mobidiag

June 17, 2021 MARLBOROUGH, Mass.–(BUSINESS WIRE)– Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously… The post Hologic closes acquisition of Mobidiag appeared first on Mobidiag.

Read full article »

Mobidiag's Competitors | Mobidiag's News | Mobidiag's Financials

Followers on Owler

195

Est. Annual Revenue

$25-100M

Est. Employees

100-250

CEO

Tuomas Tenkanen

CEO Approval Rating

90/100

Mobidiag is a Finland-based biotechnology company that manufactures and commercialization of vaccine products for the prevention and treatment of infectious diseases.

Mobidiag Blog Hologic closes acquisition of Mobidiag

June 17, 2021 MARLBOROUGH, Mass.&#8211;(BUSINESS WIRE)&#8211; Hologic, Inc. (Nasdaq: HOLX), a global leader in women&#8217;s health, has completed its previously&#8230; The post Hologic closes acquisition of Mobidiag appeared first on Mobidiag.

Followers on Owler

June 17, 2021 MARLBOROUGH, Mass.–(BUSINESS WIRE)– Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, has completed its previously… The post Hologic closes acquisition of Mobidiag appeared first on Mobidiag.